Encube Ethicals files papers with Sebi for Rs 3,000 cr IPO

Specialty pharmaceutical firm Encube Ethicals has filed preliminary papers for a Rs 3,000 crore Initial Public Offering. This public offering is entirely an offer for sale by existing shareholders. The company serves over 160 pharmaceutical firms across 50 countries globally. Encube Ethicals reported Rs 1,848.7 crore in revenue and Rs 436.7 crore net profit in FY26. The shares are proposed to be listed on both the BSE and NSE exchanges.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *